76 related articles for article (PubMed ID: 1919296)
1. Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
Thurmond LM; Brand CM; Leventhal BG; Finter NB; Johnston JM
J Lab Clin Med; 1991 Sep; 118(3):232-40. PubMed ID: 1919296
[TBL] [Abstract][Full Text] [Related]
2. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.
Leventhal BG; Kashima HK; Mounts P; Thurmond L; Chapman S; Buckley S; Wold D
N Engl J Med; 1991 Aug; 325(9):613-7. PubMed ID: 1861694
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of the formation of interferon neutralizing antibodies and their influence on the effectiveness of interferon therapy in children with juvenile respiratory papillomatosis].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Mezentseva MV; Kas'ianova NV; Tsvetnova MV; Kol'tsov VD
Vestn Otorinolaringol; 2000; (4):22-5. PubMed ID: 11011574
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neutralizing antibodies in patients treated with recombinant interferon-beta ser.
Larocca AP; Leung SC; Marcus SG; Colby CB; Borden EC
J Interferon Res; 1989 Sep; 9 Suppl 1():S51-60. PubMed ID: 2809278
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical characterization of human antibodies to lymphoblastoid interferon.
Thurmond LM; Reese MJ
Clin Exp Immunol; 1991 Dec; 86(3):514-9. PubMed ID: 1747959
[TBL] [Abstract][Full Text] [Related]
7. Detection and incidence of neutralizing antibodies to interferon-alpha-n1.
Weck PK; Leventhal BG; Brand C; Finter NB
J Interferon Res; 1989 Sep; 9 Suppl 1():S37-43. PubMed ID: 2553830
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha].
Mao QG; Luo KX; Liu DL; Zhang MX; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):205-7. PubMed ID: 15099466
[TBL] [Abstract][Full Text] [Related]
9. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha.
Jorns C; Holzinger D; Thimme R; Spangenberg HC; Weidmann M; Rasenack J; Blum HE; Haller O; Kochs G
J Med Virol; 2006 Jan; 78(1):74-82. PubMed ID: 16299717
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies to alpha-2A interferon in children with juvenile respiratory papillomatosis].
Kol'tsov VD; Onufrieva EK; Chireshkin DG; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1995; (5):24-6. PubMed ID: 7502448
[TBL] [Abstract][Full Text] [Related]
11. [The influence of interferon alpha neutralizing antibodies on the therapeutic effectiveness in patients with chronic viral hepatitis].
Tong F; Tang Y; Bai J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):345-7. PubMed ID: 12759973
[TBL] [Abstract][Full Text] [Related]
12. [Generation of neutralizing anti-interferon antibodies and factors influencing their production in chronic hepatitis B patients receiving recombinant interferon-alpha treatment].
Mao QG; Luo KX; Zhang MX; Liu D; Hou JL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1319-22. PubMed ID: 14678902
[TBL] [Abstract][Full Text] [Related]
13. [Antibodies against alpha-2 and gamma-interferons affect the course of juvenile respiratory papillomatosis in children treated with alpha-2 interferon preparations].
Kol'tsov VD; Onufrieva EK; Nurmukhamedov RKh; Malinovskaya VV; Yershov FI
Vestn Otorinolaringol; 1997; (4):13-5. PubMed ID: 9334008
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to interferon in patients undergoing IFN therapy: an update.
Antonelli G
J Biol Regul Homeost Agents; 1995; 9(4):123-31. PubMed ID: 8844336
[TBL] [Abstract][Full Text] [Related]
15. [Natural killer activity in respiratory papillomatosis and its changes after interferon treatment].
Pritsker AD; Grigorian SS; Onufrieva EK; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):409-11. PubMed ID: 1803776
[TBL] [Abstract][Full Text] [Related]
16. [The interferon status and circulating immunoglobulins during the interferon therapy of respiratory papillomatosis in children].
Pritsker AD; Grigorian SS; Onufrieva SS; Chireshkin DG; Ershov FI
Vopr Virusol; 1991; 36(5):411-4. PubMed ID: 1725077
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of pulmonary metastasis from recurrent respiratory papillomatosis.
Silver RD; Rimell FL; Adams GL; Derkay CS; Hester R
Otolaryngol Head Neck Surg; 2003 Dec; 129(6):622-9. PubMed ID: 14663426
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
19. Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
Gneiss C; Tripp P; Ehling R; Khalil M; Lutterotti A; Egg R; Mayringer I; Künz B; Berger T; Reindl M; Deisenhammer F
J Neuroimmunol; 2006 May; 174(1-2):174-9. PubMed ID: 16556466
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study.
Kappos L; Clanet M; Sandberg-Wollheim M; Radue EW; Hartung HP; Hohlfeld R; Xu J; Bennett D; Sandrock A; Goelz S;
Neurology; 2005 Jul; 65(1):40-7. PubMed ID: 16009883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
